Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Phase I trial of Lipovaxin-MM, a novel dendritic cell-targeted liposomal vaccine for malignant melanoma
Tessa Gargett, M. Nazim Abbas, Paul Rolan, et al.
Cancer Immunology Immunotherapy (2018) Vol. 67, Iss. 9, pp. 1461-1472
Open Access | Times Cited: 96

Showing 1-25 of 96 citing articles:

Immunomodulatory Nanosystems
Xiangru Feng, Weiguo Xu, Zhongmin Li, et al.
Advanced Science (2019) Vol. 6, Iss. 17
Open Access | Times Cited: 318
Ligand‐Installed Nanocarriers toward Precision Therapy
Peng Mi, Horacio Cabral, Kazunori Kataoka
Advanced Materials (2019) Vol. 32, Iss. 13
Closed Access | Times Cited: 301
Nanomedicine in cancer therapy
Dahua Fan, Yongkai Cao, Meiqun Cao, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 287
Application of Nanotechnology in Cancer Diagnosis and Therapy - A Mini-Review
Cancan Jin, Kankai Wang, Anthony Oppong‐Gyebi, et al.
International Journal of Medical Sciences (2020) Vol. 17, Iss. 18, pp. 2964-2973
Open Access | Times Cited: 264
Nanoparticles in Clinical Translation for Cancer Therapy
Deepa Mundekkad, William C. Cho
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1685-1685
Open Access | Times Cited: 184
Engineering Nanoparticles for Targeted Remodeling of the Tumor Microenvironment to Improve Cancer Immunotherapy
Shan Gao, Dongjuan Yang, Yan Fang, et al.
Theranostics (2018) Vol. 9, Iss. 1, pp. 126-151
Open Access | Times Cited: 166
Research progress on dendritic cell vaccines in cancer immunotherapy
Jifeng Yu, Haowei Sun, Weijie Cao, et al.
Experimental Hematology and Oncology (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 118
Melanoma Management: From Epidemiology to Treatment and Latest Advances
Joana Lopes, Cecília M. P. Rodrigues, Maria Manuela Gaspar, et al.
Cancers (2022) Vol. 14, Iss. 19, pp. 4652-4652
Open Access | Times Cited: 93
Liposome-polymer complex for drug delivery system and vaccine stabilization
Sriwidodo Sriwidodo, Abd. Kakhar Umar, Nasrul Wathoni, et al.
Heliyon (2022) Vol. 8, Iss. 2, pp. e08934-e08934
Open Access | Times Cited: 79
Nanovaccines: A game changing approach in the fight against infectious diseases
Priyanka Choudhary, Mai Abdel Haleem Abusalah, Hitesh Chopra, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 167, pp. 115597-115597
Open Access | Times Cited: 73
Lipid Nanoparticles Functionalized with Antibodies for Anticancer Drug Therapy
Ana Camila Marques, Paulo Costa, Sérgia Velho, et al.
Pharmaceutics (2023) Vol. 15, Iss. 1, pp. 216-216
Open Access | Times Cited: 47
DC-Based Vaccines for Cancer Immunotherapy
Chunmei Fu, Li Zhou, Qing‐Sheng Mi, et al.
Vaccines (2020) Vol. 8, Iss. 4, pp. 706-706
Open Access | Times Cited: 117
Physical and chemical profiles of nanoparticles for lymphatic targeting
Xiyu Ke, Gregory P. Howard, Haoyu Tang, et al.
Advanced Drug Delivery Reviews (2019) Vol. 151-152, pp. 72-93
Closed Access | Times Cited: 109
Axial pharmaceutical properties of liposome in cancer therapy: Recent advances and perspectives
Seyed Hossein Kiaie, Solmaz Mojarad-Jabali, Farnaz Khaleseh, et al.
International Journal of Pharmaceutics (2020) Vol. 581, pp. 119269-119269
Closed Access | Times Cited: 76
Chemical Conjugation Strategies for the Development of Protein-Based Subunit Nanovaccines
Lantian Lu, Viet Tram Duong, Ahmed O. Shalash, et al.
Vaccines (2021) Vol. 9, Iss. 6, pp. 563-563
Open Access | Times Cited: 73
Challenges of Current Anticancer Treatment Approaches with Focus on Liposomal Drug Delivery Systems
Vijay Gyanani, Jeffrey C. Haley, Roshan Goswami
Pharmaceuticals (2021) Vol. 14, Iss. 9, pp. 835-835
Open Access | Times Cited: 70
Sustained Drug Release from Smart Nanoparticles in Cancer Therapy: A Comprehensive Review
Xue Bai, Zara Smith, Yuheng Wang, et al.
Micromachines (2022) Vol. 13, Iss. 10, pp. 1623-1623
Open Access | Times Cited: 62
The Current State of Treatment and Future Directions in Cutaneous Malignant Melanoma
Madison Ernst, Alessio Giubellino
Biomedicines (2022) Vol. 10, Iss. 4, pp. 822-822
Open Access | Times Cited: 46
Cancer treatment and toxicity outlook of nanoparticles
N. Neetika, Mamta Sharma, Pankaj Thakur, et al.
Environmental Research (2023) Vol. 237, pp. 116870-116870
Closed Access | Times Cited: 33
Nanotechnology as a Promising Method in the Treatment of Skin Cancer
Angelika A. Adamus-Grabicka, Paweł Hikisz, Joanna Sikora
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 2165-2165
Open Access | Times Cited: 12
Recent Advances in Liposomes Efficacy as a Drug Delivery Platform for Melanoma Treatment
Elham Zarenezhad, Zahra Kazeminejad, Mahsa Rostami Chijan, et al.
Russian Journal of Bioorganic Chemistry (2025) Vol. 51, Iss. 1, pp. 93-116
Closed Access | Times Cited: 1
Antibody conjugated nanoparticles as a novel form of antibody drug conjugate chemotherapy
Michael C. Johnston, Christopher J. Scott
Drug Discovery Today Technologies (2018) Vol. 30, pp. 63-69
Open Access | Times Cited: 76
Dendritic Cells in Anticancer Vaccination: Rationale for Ex Vivo Loading or In Vivo Targeting
Alexey V. Baldin, Lyudmila V. Savvateeva, Alexandr V. Bazhin, et al.
Cancers (2020) Vol. 12, Iss. 3, pp. 590-590
Open Access | Times Cited: 69
Cell and tissue engineering in lymph nodes for cancer immunotherapy
Alexander J. Najibi, David Mooney
Advanced Drug Delivery Reviews (2020) Vol. 161-162, pp. 42-62
Open Access | Times Cited: 59
Page 1 - Next Page

Scroll to top